Cancer susceptibility mutations of BRCA1

Details Cancer susceptibility mutations of BRCA1 Cancer susceptibility mutations of BRCA1

1997-12-11

2000-07-04

Zitomer, Stephanie

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

435912, 4353201, 435810, 536 235, 536 2431, 536 2433, C12Q 168, C12Q 1934, C07H 2104, C12N 1585

Patent

active

060836989

ABSTRACT:
New mutations have been found in the BRCA1 gene. The mutations are located at nucleotide numbers 421-2, 815, 903, 926, 1506, 2034, 2428, 3888, 3904, 4164, 4643, 5053, 5150, 5210, or 5396+40 of the gene sequence of BRCA1. A process for identifying a sequence variation in a BRCA1 polynucleotide sequence is disclosed. The identification process includes allele specific sequence-based assays of known sequence variations. The methods can be used for efficient, and accurate detection of a mutation in a test BRCA1 gene sample.

REFERENCES:
patent: 5700637 (1997-12-01), Southern
patent: 5756294 (1998-05-01), White et al.

Affiliated with

Also associated with

Rating

Cancer susceptibility mutations of BRCA1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer susceptibility mutations of BRCA1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer susceptibility mutations of BRCA1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1484974